The highly reproducible pattern of programmed cell death (apoptosis) during C. elegans development is dependent on the central apoptosis pathway and its most upstream component
egl-1, which encodes a pro-apoptotic member of the Bcl-2 family of apoptosis regulators. Unlike other components of the central pathway (
ced-9,
ced-4, and
ced-3), the
egl-1 gene is predominantly transcribed in cell death lineages (i.e. lineages in which a cell death occurs), and this specificity is mediated by lineage-specific transcription factors. Within a particular cell death lineage,
egl-1 mRNA copy number is dynamic. Using single-molecule RNA FISH, we previously found a low number of
egl-1 mRNAs in mothers of cells programmed to die, a high number in daughters programmed to die and essentially zero in daughters programmed to survive. Although the mechanisms underlying this dynamic pattern are not fully understood, we have evidence that it is at least partially due to microRNA-dependent control of
egl-1 mRNA turn-over. Specifically, we reported that the miR-35 and miR-58 families of microRNAs act through respective binding sites in the
egl-1 3' UTR to increase
egl-1 mRNA turn-over in mothers, thereby preventing their precocious deaths (Sherrard et al, 2017). We have now identified additional elements in the
egl-1 3' UTR that are required for
egl-1 3' UTR-mediated repression of reporter gene expression. These elements include a conserved 3' terminal element (TPTE) that is necessary and partially sufficient to repress reporter gene expression. We hypothesize that RNA-binding proteins (RBPs) also play important roles in post-transcriptional control of
egl-1 expression. To identify functionally relevant RBPs, we individually knocked down 660 genes predicted to encode RBPs and analyzed the resulting animals with respect to
egl-1 3' UTR-dependent reporter gene expression. Using this approach, we identified 37 repressor candidates and 26 activator candidates. We are currently in the process of screening these candidates for potential cell death phenotypes and plan to verify
egl-1 mRNA-RBP interactions using biochemical approaches. We propose that regulation at the post-transcriptional level through miRNAs and potentially RBPs is crucial for spatio-temporal control of the level of
egl-1 expression in cell death lineages.